NIBRX-3829: Clear Cell Renal Cell Carcinoma

Dana-Farber Cancer Institute

Related Models
PDX model Engraftment
Host Strain Name Site Type Material Material Status Passage
Athymic Nude Subcutaneous Subcutaneous Patient Material/ direct inject Not Specified 0
Model Quality Control
Technique Description Passage
Not Specified Not Specified Not Specified
Title Combination Of Copanlisib With Cetuximab Improves Tumor Response In Cetuximab-resistant Patient-derived Xenografts Of Head And Neck Cancer.
Authors Klinghammer K, Politz O, Eder T ... Keilholz U.
Publication year 2020
Journal Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer.
Sex female
Race / Ethnicity Not specified / Unknown
Derived Model NIBRX-3829
Patient Tumor Collection For PDX Model
Collection (Current Model)
Age 60
Diagnosis Clear Cell Renal Cell Carcinoma
Type Metastatic
PDX Mouse NIBRX-3829
Collection Site diaphragm
Grade ( Classification: )
Stage ( Classification: )

Sample ID:     Histology:     Tumor Type: Engrafted Tumor     Passage:     Platform: